Bruce Jackson

Stock Analyst at Benchmark

(0.84)
# 3,809
Out of 4,883 analysts
123
Total ratings
24.58%
Success rate
-26.63%
Average return

Stocks Rated by Bruce Jackson

Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7$2.75
Current: $0.69
Upside: +295.74%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17$14
Current: $2.16
Upside: +548.15%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5$3
Current: $0.44
Upside: +577.20%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84$33
Current: $3.87
Upside: +752.71%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25$23
Current: $2.90
Upside: +693.10%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $59.03
Upside: +35.52%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.31
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $52.48
Upside: +23.86%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.67
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $4.69
Upside: +539.66%
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.68
Upside: +83.82%
Reiterates: Speculative Buy
Price Target: $3
Current: $1.18
Upside: +154.24%
Reiterates: Speculative Buy
Price Target: $5
Current: $2.17
Upside: +130.72%
Reiterates: Speculative Buy
Price Target: $30
Current: $0.68
Upside: +4,344.44%
Reiterates: Speculative Buy
Price Target: $60
Current: $3.60
Upside: +1,566.67%
Reiterates: Speculative Buy
Price Target: $17
Current: $0.37
Upside: +4,533.42%
Reiterates: Speculative Buy
Price Target: $24
Current: $1.01
Upside: +2,276.24%
Reiterates: Speculative Buy
Price Target: $1
Current: $2.91
Upside: -65.64%
Reiterates: Speculative Buy
Price Target: $5
Current: $0.73
Upside: +586.25%
Downgrades: Hold
Price Target: n/a
Current: $2.20
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $16.61
Upside: -
Initiates: Speculative Buy
Price Target: $800
Current: $3.79
Upside: +21,008.18%